Current Pharmaceutical Biotechnology

Editor-in-Chief

Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens
Athens
(Greece)

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot Topic: New Frontiers in Immunology and Infectious Diseases (Guest Editor: Stefan Borgmann)] promotion: free to download

Volume:13   Issue: 8
Pp: 1377-1377
Stefan Borgmann
DOI: 10.2174/138920112800784934
Published on: 27 May, 2012

Dendritic Cells: Elegant Arbiters in Human Reproduction

Volume:13   Issue: 8
Pp: 1378-1384
Sabine E. Segerer, Claudia Staib, Ulrike Kaemmerer, Torsten Frambach, Arnd Honig, Johannes Dietl and Lorenz Rieger
DOI: 10.2174/138920112800784916
Published on: 27 May, 2012

Monoclonal Antibodies for the Immunotherapy of Solid Tumours

Volume:13   Issue: 8
Pp: 1385-1398
Richard Mauerer and Rudolf Gruber
DOI: 10.2174/138920112800784844
Published on: 27 May, 2012

Clinical Experience with Gene Therapy and Bispecific Antibodies for T Cell-based Therapy of Cancer

Volume:13   Issue: 8
Pp: 1399-1408
Patrick A. Baeuerle and Christian Itin
DOI: 10.2174/138920112800785005
Published on: 27 May, 2012

Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair

Volume:13   Issue: 8
Pp: 1409-1417
Michael D. Carrithers
DOI: 10.2174/138920112800784781
Published on: 27 May, 2012

Infections in Patients with Rheumatic Diseases Treated with TNF Antagonists

Volume:13   Issue: 8
Pp: 1418-1425
Beatriz Perez-Zafrilla, Loreto Carmona and Juan J. Gomez-Reino
DOI: 10.2174/138920112800784808
Published on: 27 May, 2012

The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy

Volume:13   Issue: 8
Pp: 1426-1438
Verena Jendrossek
DOI: 10.2174/138920112800784989
Published on: 27 May, 2012

Recent Advances in Active Specific Cancer Vaccine Treatment for Colorectal Cancer

Volume:13   Issue: 8
Pp: 1439-1445
Kiyotaka Okuno, Fumiaki Sugiura, Kyogo Itoh, Koji Yoshida, Takuya Tsunoda and Yusuke Nakamura
DOI: 10.2174/138920112800784998
Published on: 27 May, 2012

Bacteria and their Toxins Tamed for Immunotherapy

Volume:13   Issue: 8
Pp: 1446-1473
Irena Adkins, Jana Holubova, Martina Kosova and Lenka Sadilkova
DOI: 10.2174/138920112800784835
Published on: 27 May, 2012

Editorial [Hot Topic: New Treatment Strategies in Schizophrenia Beyond Dopamine: Glutamatergic Neurotransmission and More (Guest Editor: Christoph Mulert & Elizabeth Scarr)] promotion: free to download

Volume:13   Issue: 8
Pp: 1474-1475
C. Mulert
DOI: 10.2174/138920112800784871
Published on: 27 May, 2012

Pharmacotherapy of Schizophrenic Patients: Achievements, Unsolved Needs, Future Research Necessities

Volume:13   Issue: 8
Pp: 1476-1489
Hans-Jurgen Moller
DOI: 10.2174/138920112800784907
Published on: 27 May, 2012

Subjective Well-being of Patients with Schizophrenia as a Target of Drug Treatment

Volume:13   Issue: 8
Pp: 1490-1499
E. Karamatskos, C. Mulert, M. Lambert and D. Naber
DOI: 10.2174/138920112800784862
Published on: 27 May, 2012

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Volume:13   Issue: 8
Pp: 1500-1512
Alice Egerton and James M. Stone
DOI: 10.2174/138920112800784961
Published on: 27 May, 2012

DTNBP1 (Dysbindin) Gene Variants: In Vivo Evidence for Effects on Hippocampal Glutamate Status

Volume:13   Issue: 8
Pp: 1513-1521
C. Wirth, F. Schubert, M. Lautenschlager, R. Bruhl, A. Klar, T. Majic, U. E. Lang, A. Ehrlich, G. Winterer, T. Sander, M. Schouler-Ocak and J. Gallinat
DOI: 10.2174/138920112800784952
Published on: 27 May, 2012

Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Treatments

Volume:13   Issue: 8
Pp: 1522-1534
L. J. Gray, A. J. Hannan and X. Zhang
DOI: 10.2174/138920112800784817
Published on: 27 May, 2012

Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia

Volume:13   Issue: 8
Pp: 1535-1542
Robert E. McCullumsmith, John Hammond, Adam Funk and James H. Meador-Woodruff
DOI: 10.2174/138920112800784899
Published on: 27 May, 2012

From Glutamatergic Dysfunction to Cognitive Impairment: Boundaries in the Therapeutic of the Schizophrenia

Volume:13   Issue: 8
Pp: 1543-1548
P. A. Gaspar, M. L. Bustamante, L. E. Rojo and A. Martinez
DOI: 10.2174/138920112800784790
Published on: 27 May, 2012

Disturbed Function of GABAergic Interneurons in Schizophrenia: Relevance for Medical Treatment?

Volume:13   Issue: 8
Pp: 1549-1556
J. Genius, I. Giegling, J. Benninghoff and D. Rujescu
DOI: 10.2174/138920112800784943
Published on: 27 May, 2012

Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies

Volume:13   Issue: 8
Pp: 1557-1562
Ana D. Stan and David A. Lewis
DOI: 10.2174/138920112800784925
Published on: 27 May, 2012

Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

Volume:13   Issue: 8
Pp: 1572-1586
H. Y. Meltzer, B. W. Massey and M. Horiguchi
DOI: 10.2174/138920112800784880
Published on: 27 May, 2012

Treating Impaired Cognition in Schizophrenia

Volume:13   Issue: 8
Pp: 1587-1594
H. M. Ibrahim and C. A. Tamminga
DOI: 10.2174/138920112800784772
Published on: 27 May, 2012

Immunological Treatment Options for Schizophrenia

Volume:13   Issue: 8
Pp: 1606-1613
Norbert Muller, Aye-Mu Myint and Markus J. Schwarz
DOI: 10.2174/138920112800784826
Published on: 27 May, 2012

Current Progress in the Genetic Research of Schizophrenia: Relevance for Drug Discovery?

Volume:13   Issue: 8
Pp: 1614-1621
Dan Rujescu, Just Genius, Jens Benninghoff and Ina Giegling
DOI: 10.2174/138920112800784754
Published on: 27 May, 2012

Functional Magnetic Resonance Imaging and Treatment Strategies in Schizophrenia

Volume:13   Issue: 8
Pp: 1622-1629
Susanne Karch, Oliver Pogarell and Christoph Mulert
DOI: 10.2174/138920112800784853
Published on: 27 May, 2012